Oxcarbazepine Tablet, Film Coated
NDC Package 60429-062-01
Package Information
Oxcarbazepine tablets is oxcarbazepine is used alone or with other medications to treat seizure disorders (epilepsy). This formulation utilizes a tablet, film coated delivery system. Marketed by Golden State Medical Supply, Inc., this product is identified by NDC 60429-062 and is authorized under FDA application ANDA078069.
Identification & Billing
- RxCUI: 312136 - OXcarbazepine 150 MG Oral Tablet
- RxCUI: 312136 - oxcarbazepine 150 MG Oral Tablet
- RxCUI: 312137 - OXcarbazepine 300 MG Oral Tablet
- RxCUI: 312137 - oxcarbazepine 300 MG Oral Tablet
- RxCUI: 312138 - OXcarbazepine 600 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 60429 - Golden State Medical Supply, Inc.
- 60429-062 - Oxcarbazepine
- 60429-062-01 - 100 TABLET, FILM COATED in 1 BOTTLE
- 60429-062 - Oxcarbazepine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (60429-062). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 60429-062-01 identifies a specific commercial package of 100 tablet, film coated in 1 bottle of Oxcarbazepine, a human prescription drug labeled by Golden State Medical Supply, Inc.. This tablet, film coated is formulated for oral use and contains oxcarbazepine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Golden State Medical Supply, Inc. on January 11, 2008. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Oxcarbazepine is used alone or with other medications to treat seizure disorders (epilepsy).
How is this Golden State Medical Supply, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 60429006201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.